For: | Li YM, Bie ZX, Guo RQ, Li B, Wang CE, Yan F. Effect of hepatic artery resection and reconstruction on the prognosis of patients with advanced hilar cholangiocarcinoma. World J Gastrointest Oncol 2022; 14(4): 887-896 [PMID: 35582106 DOI: 10.4251/wjgo.v14.i4.887] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i4/887.htm |
Number | Citing Articles |
1 |
Jie-ping Wang, Meng-yu Zhang, Ming Luo, Shu Qin, Xian-ming Xia. Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23539-5
|
2 |
Abdullah K. Malik, Brian R. Davidson, Derek M. Manas. Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma. European Journal of Surgical Oncology 2024; : 108248 doi: 10.1016/j.ejso.2024.108248
|
3 |
Yi-Xian Huang, Chao Xu, Cheng-Cheng Zhang, Guang-Yi Liu, Xing-Chao Liu, Hai-Ning Fan, Bi Pan, Yuan-Cheng Li. Vascular reconstruction provides short-term and long-term survival benefits for patients with hilar cholangiocarcinoma: A retrospective, multicenter study. Hepatobiliary & Pancreatic Diseases International 2024; doi: 10.1016/j.hbpd.2024.05.001
|
4 |
Nicholas Holt, Joanna Lee, Ngee Soon Lau, Natalie Collier, Oliver M. Fisher, Carlo Pulitano, Katrin Sjoquist, Craig Philip I.. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 407 doi: 10.1002/9781119756422.ch21
|